Eric A. Jonasch, MD, MD Anderson Cancer Center

home / authors / eric-a-jonasch-md-md-anderson-cancer-center

Articles

Experts on RCC

Relapsed/Refractory Clear Cell RCC: Novel Treatment Strategies

Brian I. Rini, MD;Eric A. Jonasch, MD, MD Anderson Cancer Center;Elizabeth R. Plimack, MD, MS, Fox Chase Cancer Center;Bruno R. Bastos, MD, Miami Cancer Institute ;Stephanie Berg, DO
July 17th 2023

Switching their focus to relapsed/refractory advanced clear cell renal cell carcinoma, key opinion leaders review treatment options in this setting.

Read More

Expert on RCC

Second-Line Treatment Armamentarium in Clear Cell RCC

Brian I. Rini, MD;Eric A. Jonasch, MD, MD Anderson Cancer Center;Elizabeth R. Plimack, MD, MS, Fox Chase Cancer Center;Bruno R. Bastos, MD, Miami Cancer Institute ;Stephanie Berg, DO
July 17th 2023

Comprehensive insight to treatment options available in the second-line setting of advanced clear cell renal cell carcinoma.

Read More

Experts on RCC

Rationale Behind Discontinuing IO Therapy in Clear Cell RCC

Brian I. Rini, MD;Eric A. Jonasch, MD, MD Anderson Cancer Center;Elizabeth R. Plimack, MD, MS, Fox Chase Cancer Center;Bruno R. Bastos, MD, Miami Cancer Institute ;Stephanie Berg, DO
July 10th 2023

Focused discussion on the rationale behind discontinuing (or continuing) immunotherapy for patients with advanced clear cell renal cell carcinoma.

Read More

Experts on RCC

Selecting Therapy for a Real-World Patient With Clear Cell RCC

Brian I. Rini, MD;Eric A. Jonasch, MD, MD Anderson Cancer Center;Elizabeth R. Plimack, MD, MS, Fox Chase Cancer Center;Bruno R. Bastos, MD, Miami Cancer Institute ;Stephanie Berg, DO
July 10th 2023

Centering discussion on a patient scenario of advanced clear cell renal cell carcinoma, panelists reflect on how they would approach selecting first-line therapy.

Read More